Healx Logo

Updates

News

Latest news posts

news image
5 November 2019
Michale Bouskila-Chubb recognised in 50 Movers and Shakers in BioBusiness Report

Michale has been featured in recognition of her contribution to Healx’s business through the negotiation and closing of the company’s first pharma deals, navigating new issues such as data use and IP in drug discovery deals using artificial intelligence (AI). In addition to this, Michale has been instrumental in developing Healx’s business activities through two … Continued

news image
1 November 2019
Healx scientists present two new papers at EMNLP 2019 in Hong Kong

Poster #1: Deep Bidirectional Transformers for Relation Extraction without Supervision  NLP Scientist, Yannis Papanikolaou, will be presenting his work on relationship extraction, using a fine-tuning of Google’s BERT language model. Being able to successfully extract relationships despite scarce data is vital to discovering treatments for rare diseases, for which funds – and therefore research – … Continued

5 November 2019
Michale has been featured in recognition of her contribution to Healx’s business through the negotiation and closing of the company’s first pharma deals, navigating new issues such as data use and IP in drug discovery deals using artificial intelligence (AI). In addition to this, Michale has been instrumental in developing Healx’s business activities through two … Continued
1 November 2019
Poster #1: Deep Bidirectional Transformers for Relation Extraction without Supervision NLP Scientist, Yannis Papanikolaou, will be presenting his work on relationship extraction, using a fine-tuning of Google’s BERT language model. Being able to successfully extract relationships despite scarce data is vital to discovering treatments for rare diseases, for which funds – and therefore research – … Continued
Healx team photo
16 October 2019
Cambridge, UK – 16 October, 2019 – Healx, the AI-powered and patient-inspired technology company specialising in treatments for rare diseases, today announces that it has raised $56 million in a Series B financing round, led by one of Europe’s largest VC firms Atomico and joined by Intel Capital, Global Brain and btov Partners. All previous … Continued
brain scans
3 October 2019
We are delighted to announce a collaboration with scientists at the Institute of Cancer Research (ICR) to discover new possible ways of treating diffuse intrinsic pontine glioma (DIPG), a life-limiting childhood brain cancer for which no treatments currently exist. The ICR is an internationally-renowned research centre in the study of childhood cancers, including in DIPG, … Continued
Dr Neil Thompson gives a presentation at Healx
11 July 2019
We are pleased to announce the appointment of Neil Thompson, PhD, as Chief Scientific Officer (CSO). Neil will spearhead the expansion of the drug discovery and development team at Healx, as the company continues its growth as a leading AI-powered, next-generation biopharmaceutical company. Healx is pioneering in that it takes a patient-first approach and integrates … Continued
28 February 2019
Healx (healx.io), today announced a partnership with Boston Children’s Hospital and Barth Syndrome Foundation (BSF) to advance promising therapeutic compounds using a novel approach that will accelerate drug discovery for applications in Barth syndrome
3 October 2018
Kate has extensive expertise in drug discovery and her appointment underlines our mission to combine deep pharmacological expertise with Artificial Intelligence
26 July 2018
We are delighted to announce $10 million Series A funding round, led by Balderton Capital. Existing investors, Jonathan Milner and Amadeus Capital Partners also participated in the round.
14 March 2018
The Business Weekly article also covers the appointment of Shaun Grady, a leading business development executive at Astra Zeneca, to Healx's board of directors
16 August 2017
Erin Oerton, a PhD student at the University of Cambridge and data scientist at Healx, has won the poster prize for the Systems Medicine track at the 2nd Interdisciplinary Signalling Workshop in Visegrad, Hungary.